tiprankstipranks
Ember Therapeutics Inc (EMBT)
OTHER OTC:EMBT
US Market

Ember Therapeutics (EMBT) Financial Statements

4 Followers

Ember Therapeutics Financial Overview

Ember Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Ember Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 15Jun 15Mar 15Dec 14Sep 14
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ 252.00$ -5.84K$ -3.79K$ -4.55K$ -3.92K
EBITDA$ 252.00$ -5.84K$ -3.79K$ -4.55K$ -3.92K
Net Income Common Stockholders$ -1.35K$ -7.40K$ -5.28K$ -6.06K$ -5.42K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.30K$ 2.83K$ 2.34K$ 184.00$ 2.18K
Total Assets$ 2.30K$ 2.83K$ 2.34K$ 184.00$ 2.18K
Total Debt$ 214.62K$ 209.12K$ 207.12K$ 200.62K$ 199.47K
Net Debt$ 212.31K$ 206.29K$ 204.77K$ 200.43K$ 197.28K
Total Liabilities$ 254.80K$ 253.97K$ 246.09K$ 238.65K$ 234.59K
Stockholders Equity$ -252.50K$ -251.15K$ -243.75K$ -238.47K$ -232.41K
Cash Flow-
Free Cash Flow$ -6.02K$ -1.52K$ -4.34K$ -3.15K$ -2.57K
Operating Cash Flow$ -6.02K$ -1.52K$ -4.34K$ -3.15K$ -2.57K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 5.50K$ 2.00K$ 6.50K$ 1.15K$ 3.50K
Currency in USD

Ember Therapeutics Earnings and Revenue History

Ember Therapeutics Debt to Assets

Ember Therapeutics Cash Flow

Ember Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis